Category
Ruxolitinib
CAS Number
3016399-21-3
Molecular Formula
C17H19N5O2
Molecular Weight
325.4 g/mol
Synonym

3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanoic acid; Ruxolitinib Impurity 8

Keywords
Intermediates
Impurities
Metabolites.
Pharmaceutical Standards
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Ruxolitinib Acid Impurity (Racemic) is a racemic impurity of the drug ruxolitinib, formed during manufacturing or degradation. It is mainly used as a reference standard for quality control and analytical testing in pharmaceutical production.